SS

Sri Sriadibhatla

Director, Healthcare Investment Group at Ben Franklin Technology Partners of Southeastern Pennsylvania

Philadelphia, Pennsylvania

Overview 

Sri Sriadibhatla is the Director of the Healthcare Investment Group at Ben Franklin Technology Partners of Southeastern Pennsylvania, with a background in investments, start-ups, healthcare, and venture capital. With a PhD in Drug Delivery and experience in technology scouting and commercialization, Sri has excelled in leading strategic alliances and technology transfer initiatives in the pharmaceutical industry. Highlights of Sri's career include serving in key roles at Ben Franklin Technology Partners and FMC, focusing on investments in healthcare start-ups and utilizing expertise in drug delivery, formulation, and regulatory affairs to drive successful collaborations and technology commercialization projects.

Work Experience 

  • Director, Healthcare Investment Group

    2021 - Current

  • Senior Manager

    2017 - 2021

    Source, evaluate and manage a portfolio of early stage life science companies (digital health, med tech, therapeutics and diagnostics) in the Technology Commercialization Group.

  • Manager, Technology Commercialization Group

    2014 - 2017

    Principle support for life sciences programs and regional initiatives for Technology Commercialization Group. Also assist in the outreach and intake of clients for a full range of Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) programs and services related to the life sciences industry.

  • Technology Scout

    2011 - 2014

     Provided leadership in developing, adapting, streamlining, and executing an Open Innovation initiative focused on delivering external solutions as an enabler of growth  Worked closely with Global Strategic Marketing Group to develop growth strategies by identifying new market opportunities, product attributes and markets of interest  Built extensive network of third party strategic partners for sourcing opportunities and expert opinion  Developed business cases to support pursuit of proprietary & differentiated platform technologies, and new actives  Collaborated with scientists, project management, regulatory and legal to drive new technologies into Proof-of-Concept evaluations and into product development

  • Senior Formulation Scientist

    2007 - 2011

     Lead research programs targeted to development of controlled release formulations and managed resources for multiple projects simultaneously. Designed and performed laboratory experiments to optimize formulation compositions and process parameters. Supervised and mentored direct reports, members of junior scientific staff and summer interns.  Participated and counseled due diligence team evaluating the feasibility for in-licensing the technologies and optimized in-licensed technologies to meet the value propositions.  Extensive experience in nanotechnology & controlled release technologies, micro-encapsulation, interfacial polymerization, emulsion polymerization, polymer synthesis, colloid and rheological studies, Liquid formulations (suspoemulsion, suspension concentrate, emulsifiable concentrate, oil dispersion), and solid formulations.

FMC Corporation is an US-based chemical manufacturing company producing solutions for the agricultural, textile, and healthcare industries.

Articles About Sri

Relevant Websites